Home › NDC Lookup › Ingredients › Duloxetine Hydrochloride › 59651-0282-39
💊image loading
(from DailyMed)

Duloxetine Hydrochloride 60 mg Capsule, Delayed Release, 3,000-count — NDC 59651-282-39 (Billing 59651-0282-39)

by Aurobindo Pharma Limited · 3000 CAPSULE, DELAYED RELEASE in 1 BOTTLE

This is a package of 3,000 capsules of Duloxetine Hydrochloride 60 mg Capsule, Delayed Release from Aurobindo Pharma Limited, no longer marketed (first marketed Dec 2019), no longer in the FDA NDC Directory.

NDC 59651-0282-39
🏷️ FDA NDC (as labeled) 59651-282-39 billing pads the product segment with a zero
This package
Contains3,000-count Pack sizes6 compare ↓
Product page 59651-0282-26 Also comes in: 10 capsules 59651-282-78 30 capsules 59651-282-30 90 capsules 59651-282-90 1000 capsules 59651-282-99 2500 capsules 59651-282-26
Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Duloxetine Hydrochloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jun 4, 2026 — CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0583-2026
Class II · Jun 4, 2026 — CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0582-2026
Class II · Apr 21, 2026 — CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0522-2026
Class II · Nov 24, 2025 — CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0216-2026
Class II · Nov 24, 2025 — CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0215-2026
Class II · Oct 9, 2025 — CGMP Deviations: N-nitroso-duloxetine impurity above the safety assessment limit of 12.5ppm. (Breckenridge Pharmaceutical, Inc.) · FDA recall D-0100-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59651-282-39
Product NDC 59651-282
11-digit billing NDC 59651028239
SPL Set ID 8bb3c67d-e24c-4d40-bd6d-ef5f14d88961
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2019-12-30
Dosage form CAPSULE, DELAYED RELEASE
Substance DULOXETINE HYDROCHLORIDE
Why two NDCs? The FDA registers this code as 59651-282-39 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59651-0282-39. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats major depressive disorder and generalized anxiety disorder. It is also used for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain such as low back or os...
  • Take it by mouth, usually once a day, with or without food. Swallow the capsule whole and don’t crush, chew, or open it, unless you have Drizalma Sprinkle, which can be opened over...
  • Nausea, dry mouth, sleepiness, constipation, less appetite, and sweating are the most common. Headache and dizziness also occur. Call your doctor for yellow skin or eyes, a blister...
  • Please don’t stop suddenly. Stopping abruptly can cause discontinuation symptoms, so your prescriber will lower the dose gradually. Check in with them before making any change.
📖 Read our full Duloxetine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Duloxetine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Duloxetine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 10 capsules 30 capsules 90 capsules 1000 capsules 2500 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59651-0282-30 59651-282-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE 2013-12-11 — Active
59651-0282-39 You're viewing this 3000 CAPSULE, DELAYED RELEASE in 1 BOTTLE 2013-12-11 — Discontinued by firm
59651-0282-78 59651-282-78 10 BLISTER PACK in 1 CARTON / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK 2013-12-11 — Active
59651-0282-90 59651-282-90 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE 2013-12-11 — Active
59651-0282-99 59651-282-99 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE 2013-12-11 — Active
59651-0282-26 59651-282-26 Main listing 2500 CAPSULE, DELAYED RELEASE in 1 BAG — — Active

Pack size FAQ

What quantity is in this package?
This is a 3,000-count package — 3000 capsule, delayed release in 1 bottle.
How does this package differ from NDC 59651-0282-30?
Both are Duloxetine Hydrochloride 60 mg Capsule, Delayed Release — the drug itself is identical. This page's package is the 3,000-count one, while NDC 59651-0282-30 is the 30 capsules package.
What NDC number is used to bill for this package of Duloxetine Hydrochloride 60 mg Capsule, Delayed Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Duloxetine Hydrochloride 60 mg 33342-0162-07 Macleods 30 capsules $0.115 AB FDA listed —
Duloxetine 60 mg 00228-2892-03 Actavis 30 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 27241-0099-03 Ajanta 30 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 43547-0381-03 Solco 30 capsules $0.135 AB Availability likely —
Duloxetine Delayed-Release 60 mg 51991-0748-10 Breckenridge 1000 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 68001-0596-04 BluePoint 30 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 68180-0296-03 Lupin 1000 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 82009-0032-10 Quallent 1000 capsules $0.135 AB Availability likely —
Duloxetine 60 mg 82009-0173-10 Quallent 1000 capsules $0.135 AB Availability likely —
Cymbalta 60 mg 00002-3270-30 Eli 30 capsules $8.972 — Discontinued —
Duloxetine 60 mg 00615-8496-05 NCS 15 capsules — AB FDA listed —
Duloxetine 60 mg 25000-0610-03 MARKSANS 30 capsules — — FDA listed —
Duloxetine 60 mg 31722-0170-01 Camber 100 capsules — AB FDA listed —
Duloxetine 60 mg 42708-0196-30 QPharma, 30 capsules — AB FDA listed —
Duloxetine Hydrochloride 60 mg 46708-0280-10 Alembic 100 capsules — AB FDA listed —
Duloxetine 60 mg 47335-0383-08 Sun 100 capsules — — FDA listed —
duloxetine 60 mg 49252-0009-10 Inventia 30 capsules — AB FDA listed —
Duloxetine 60 mg 50090-5940-00 A-S 30 capsules — AB FDA listed —
Duloxetine 60 mg 50090-6775-00 A-S 30 capsules — AB FDA listed —
Duloxetine 60 mg 50090-6893-00 A-S 90 capsules — AB FDA listed —
Duloxetine 60 mg 50090-7897-00 A-S 90 capsules — AB FDA listed —
Duloxetine Hydrochloride 60 mg 50771-0203-01 Yaopharma 30 capsules — — FDA listed —
Duloxetine Delayed-Release 60 mg 51407-0819-10 Golden 1000 capsules — AB FDA listed —
Duloxetine 60 mg 51655-0237-25 Northwind 60 capsules — AB FDA listed —
Duloxetine Hydrochloride 60 mgthis 59651-0282-39 Aurobindo 3000 capsules — — Discontinued —
Duloxetine 60 mg 60760-0462-30 St. 30 capsules — AB Discontinued —
Duloxetine Hydrochloride 60 mg 62332-0280-30 Alembic 30 capsules — AB FDA listed —
Duloxetine 60 mg 63187-0666-30 Proficient 30 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 63187-0735-30 Proficient 30 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 63629-1992-01 Bryant 90 capsules — AB FDA listed —
Duloxetine 60 mg 63629-8748-01 Bryant 30 capsules — AB FDA listed —
Duloxetine 60 mg 65841-0801-06 Zydus 30 capsules — AB FDA listed —
Duloxetine 60 mg 67046-1598-03 Coupler 30 capsules — AB FDA listed —
Duloxetine 60 mg 67877-0265-01 Ascend 100 capsules — AB FDA listed —
Duloxetine 60 mg 68071-3519-03 NuCare 30 capsules — AB FDA listed —
Duloxetine 60 mg 68071-3775-09 NuCare 90 capsules — AB FDA listed —
Duloxetine 60 mg 68788-4026-03 Preferred 30 capsules — AB FDA listed —
Duloxetine 60 mg 68788-7672-00 Preferred 6 capsules — AB FDA listed —
Duloxetine 60 mg 68788-8623-03 Preferred 30 capsules — AB FDA listed —
duloxetine 60 mg 70247-0014-03 Qingdao 30 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 70518-0122-05 REMEDYREPACK 90 capsules — AB FDA listed —
Duloxetine 60 mg 70518-1011-00 REMEDYREPACK 30 capsules — AB FDA listed —
Duloxetine 60 mg 70518-1244-00 REMEDYREPACK 30 capsules — AB FDA listed —
Duloxetine 60 mg 70518-2630-01 REMEDYREPACK 30 capsules — AB Discontinued —
Duloxetine 60 mg 71205-0358-30 Proficient 30 capsules — AB FDA listed —
Duloxetine 60 mg 71335-0402-01 Bryant 30 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 71335-0509-01 Bryant 30 capsules — AB Discontinued —
Duloxetine 60 mg 71335-1445-01 Bryant 30 capsules — AB Discontinued —
Duloxetine 60 mg 71335-2567-01 Bryant 30 capsules — AB FDA listed —
Duloxetine 60 mg 71335-2625-01 Bryant 30 capsules — AB FDA listed —
Duloxetine 60 mg 71610-0403-60 Aphena 90 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 71610-0743-30 Aphena 30 capsules — AB FDA listed —
Duloxetine 60 mg 72162-1058-03 Bryant 30 capsules — AB FDA listed —
Duloxetine Delayed-Release 60 mg 72162-1599-01 Bryant 100 capsules — AB FDA listed —
Duloxetine D/R 60 mg 72189-0608-30 Direct_Rx 30 capsules — AB FDA listed —
Duloxetine 60 mg 72789-0338-90 PD-Rx 90 capsules — AB FDA listed —
Duloxetine 60 mg 76420-0623-01 Asclemed 100 capsules — AB FDA listed —
Duloxetine DR 60 mg 80425-0119-01 Advanced 30 capsules — AB FDA listed —
Duloxetine 60 mg 80425-0389-01 Advanced 30 capsules — AB FDA listed —
Duloxetine Hydrochloride 60 mg 73476-0748-00 Towa 55000 capsules — — FDA listed —
Duloxetine hydrochloride 60 mg 00110-3270-05 Lilly 150000 capsules — — FDA listed —
Duloxetine hydrochloride 60 mg 00110-9542-15 Lilly 155000 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Dec 2019
📍
2026
Currently FDA-listed
7 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code59651
First marketedDec 2019
Product typeDrug For Further Processing
Portfolio1,456 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Listed for further processing / repackaging No longer marketed (per FDA listing data)

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 10 capsules (59651-0282-78), 30 capsules (59651-0282-30), 90 capsules (59651-0282-90). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 59651-0280-30 · Aurobindo 59651-0285-01 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.